Arno F.G

Apr 17, 2024 | karger.com | Arno F.G |Van Kampen |Vivian E.M |van der Krieken

Keywords: COVID-19, Pulmonary embolism, Epidemiology, Hospital ward, Vascular research Already in the first wave of the SARS-CoV-2 pandemic, elevated biochemical markers for blood clotting activation, like D-dimers, were observed in COVID-19 patients [1‒3]. Whether venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and PE, occurred more frequently in these patients had not yet been clarified.